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LETTERS TO THE EDITOR
Comments on the
Proposed New
International Lymph
Node International
Association for the
Study of Lung Cancer
Map
To the Editor:
We are all grateful to Rusch et al.1
for their effort to develop a new nodal
map for staging lung cancer, dividing
the levels according to landmarks that
would be easier to be identified by sur-
geons and by radiologists. As described
in their article, the necessity of a new
unified nodal map becomes obvious with
the historical review and the difficulties
they found when trying to compare data
from lung cancer patients staged using the
previously available Naruke’s and Moun-
tain-Dressler ATS maps.
The illustrations of Dr. Annie Fra-
zier for the new International Association
for the Study of Lung Cancer map are
very beautiful. We like to congratulate her
for her efforts in translating this complex
anatomy into drawings. However, consid-
ering that the map is to be accepted and
used worldwide, it should be anatomically
precise, and the corresponding article and
the drawings should be universally acces-
sible, without copyright limitations. Addi-
tionally, without diminishing the excel-
lence of their work, we like to make few
observations on the anatomic details that
should be reviewed:
1. In the text, the authors refer to the
pulmonary trunk as “main pulmo-
nary artery,” and in the drawings, it
is abbreviated as “mPA.” According
to the Federative Committee on An-
atomic Terminology,2 the correct
denomination is pulmonary trunk.
2. Some characteristics of the air-
ways have not been preserved. In
particular, the proportion among
the length of the main bronchi, the
length of the upper lobe bronchi,
the ramification of the left upper
lobe bronchus, and the length, ori-
entation, and order of appearance
of the segmental bronchi. Some
nodal stations are demarcated by
division of the airways, so the map
needs to be accurate. Also, we will
be using the map on a daily basis,
for the next 7 years, to teach our
trainees and medical students. We
would not like to be pointing out
the imperfections or would we like
them to have a distorted impres-
sion of the anatomy.
3. The article proposes that the sub-
carinal nodal station (level 7) is de-
limited by the tracheal carina and
the lower border of the bronchus
intermedius on the right and by the
upper border of the left lower lobe
bronchus on the opposite side. Re-
viewing the drawings, there are sub-
carinal nodes below the level of the
upper aspect of the left lower lobe
bronchus (refer to the Fig. 3 in the
original article1).
4. The definition of new boundaries to
the level 10 nodes (hilar nodes) is of
a major concern. Pulmonary hilum
is defined as the depression in the
medial surface of a lung (not of the
mediastinum), through which pass
the bronchus, vessels, and nerves.
Radiologists have been using the
term pulmonary hilum as a portion
of the lungs. The radiologic hilum is
defined as the composite shadow of
the main pulmonary arteries, veins,
and lymph nodes in the lung root,
adjacent to the anatomic hilum,
which is the actual opening of the
mediastinal pleura for the passage of
these structures. According to the
proposed new boundaries, the con-
cept of hilum has been misrepre-
sented, and some hilar nodes are
now within the mediastinum, within
the boundaries of the mediastinal
pleura, and not in the hilum of the
lungs. With all respect to the group
who put this huge effort into defin-
ing the new nodal map, this concept
of “pulmonary hilum within the me-
diastinum” needs to be reviewed.
We hope you find our suggestions
pertinent.
Klaus L. Irion, PhD, FRCR
Hilary Fewins, MBBS, FRCR
Sukumaran Binukrishnan, MBBS,
FRCR
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Liverpool Heart and Chest Hospital
Liverpool, United Kingdom
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In Response:
Irion et al. raise several issues re-
garding nomenclature in our recently
published article describing the pro-
posed new international IASLC lymph
node map. Our responses to their points
are as follows:
1. We understand that the recom-
mended nomenclature for the main
pulmonary artery in the source
cited by Irion et al. is “pulmonary
trunk.” However, this is not a term
commonly used by clinicians or
radiologists. We have chosen to
use terminology widely accepted
in clinical practice.
2. and 3. The figures provided for the
lymph node map are intended to
serve as an illustrative guide for
clinicians and radiologists. Dr. Fra-
zier was especially well positioned
to do these illustrations because she
is a practicing radiologist as well as
a medical illustrator. Her final il-
lustrations were based on a more
schematic version of the lymph
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node map developed by the De-
partment of Medical Graphics at
Memorial Sloan-Kettering Cancer
Center in collaboration with Drs.
Rusch and Asamura and members
of the IASLC Staging Committee.
Poster size versions of both Dr.
Frazier’s illustrations and the earlier
Memorial Sloan-Kettering Cancer
Center version of the lymph node
map along with other educational
materials relevant to the new lung
cancer staging system are now eas-
ily available through the web site
of the IASLC (www.iaslc.org).
Irion et al. will be able to appreci-
ate on these magnified versions of
the map that the boundaries of the
subcarinal lymph nodes correspond to
those described in the table accom-
panying the map. However, no illus-
tration can fully portray the compli-
cated three-dimensional anatomy of
the lung, pulmonary vessels, and
mediastinum. Therefore, we encour-
age physicians to refer to the table of
anatomic definitions for the lymph
node stations included in our article.
4. The boundaries between lymph
node stations 7 and 10 have long
been a source of controversy, es-
pecially among thoracic surgeons.
Indeed, it was this very issue that
led to the major discrepancy in
nodal staging between the cases
submitted to the IASLC database
from Japan as opposed to those
from other countries. We would
again refer Irion et al. to the table
of anatomic definitions in our arti-
cle to clarify the issue of the bound-
aries between lymph node stations 7
and 10. Station 10 lymph nodes are
not in the mediastinum. Again, the
two-dimensional anatomy of medi-
cal illustrations or even of computed
tomography scans often does not al-
low a full understanding of the
three-dimensional anatomy of the
patient. A trip to the operating room
to see the actual anatomy of these
areas and the boundaries of various
lymph node stations as demon-
strated by a thoracic surgeon who
performs systematic lymph node
dissection can be very instructive.
Accessing the station 7 lymph nodes
requires incising the mediastinal
pleura, whereas accessing the station
10 lymph nodes does not.
We appreciate the interest of Irion
et al. in our work and their thoughtful
review of our article.
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